Emotion regulation among African American infants and their coparents in the context of triangular interactions at 12 months post-partum
Abstract
Emotion regulation (ER) during infancy is largely interpersonal, with dyadic studies of mutual regulation revealing how interactions are co-constructed moment by moment. However infant ER in triadic (father-mother-infant) context, the most common context for infant-father engagement during the first year, has rarely been considered. This report presents a new observational system, measuring infant triangular emotion regulation (MITER), for assessing ER strategies in three-person family interactions. Sixty-nine African American infants and their parents, participants in a U.S randomized controlled trial testing effects of a prenatal intervention to promote coparenting were videorecorded in the Lausanne Trilogue Play 12 months after birth. Coders documented infant gaze, affective configurations, parental responses to bids, infant responses to parent ministrations, and ER outcomes (successfully assisted, unsuccessfully assisted, or self-regulated). Interactions were evaluated for coparenting quality, and parents reported on coparenting, depressive symptoms, and infant emotional expression. Families receiving prenatal intervention showed modest evidence of more effective triangular processes, and both successful and unsuccessful ER strategies were associated in hypothesized directions with observational and self-report indices. Multilevel analyses showed that in families with more unsuccessful ER, parental depressive symptoms had a stronger impact on child negative emotionality.…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.